BACKGROUND Ovarian tissue cryopreservation involves freezing and storing of surgically
retrieved ovarian tissue in liquid or vapour nitrogen below–190° C. The tissue can be …

Primary ovarian insufficiency (POI) is an uncommon yet devastating occurrence that results
from a premature depletion of the ovarian pool of primordial follicles. Our understanding of …

Background Healthy individuals and patients with cancer who are carriers of germline
pathogenic variants in the BRCA1/2 genes face multiple reproductive challenges that …

Increasing numbers of women are undergoing oocyte or tissue cryopreservation for medical
or social reasons to increase their chances of having genetic children. Social egg freezing …

Cancer during childhood and adolescence remains a major public health issue, affecting a
significant portion of this age group. Although newer anti-cancer treatments have improved …

The application of decellularized scaffolds for artificial tissue reconstruction has been an
approach with great therapeutic potential in regenerative medicine. Recently, biomimetic …

Ovarian failure and ovarian malfunction are among major fertility problems in women of
reproductive age (18–35 years). It is known that various diseases, such as ovarian cancer …

Ovarian tissue cryopreservation (OTC) is the only pre-treatment option currently available to
preserve fertility for prepubescent girls and patients who cannot undergo ovarian …

After cancer treatment, female survivors often develop ovarian insufficiency or failure. Oocyte
and embryo freezing are well-established fertility preservation options, but cannot be …

Objective To report our experience with robot-assisted (RA) autologous cryopreserved
ovarian tissue transplantation (ACOTT) with the use of a neovascularizing extracellular …